Seaport Therapeutics, Inc. Common Stock
NASDAQ:SPTXBiotechnology
+$0.10 today
- Market cap
- $980.14M
- Beta
- 0.00
Volume 0.68M
Average 0.41M
SPTX Weighted Avg Shares
Average number of basic shares outstanding during the period, used to calculate basic EPS.
Weighted Avg Shares history
Shares · from the income statement
No Weighted Avg Shares data reported for this period type.
Weighted Avg Shares vs competitors
How SPTX compares with its peers on the latest reported figures
| Company | Period | LTM | YoY | 3-year CAGR |
|---|---|---|---|---|
NMRANeumora Therapeutics, Inc. Common Stock | LTM Mar 2026 | 166.7M | +4.0% | +2.4% |
| LTM Mar 2026 | 62.03M | +15.9% | +5.5% | |
| LTM Mar 2026 | 59.11M | +1.3% | +1.4% | |
| LTM Mar 2026 | 43.04M | +3.9% | +2.0% | |
RAPPRapport Therapeutics, Inc. Common Stock | LTM Mar 2026 | 41.9M | +115.2% | +32.7% |
CTNMContineum Therapeutics, Inc. Class A Common Stock | LTM Mar 2026 | 30.55M | +18.4% | +3.3% |
LBRXLB Pharmaceuticals Inc Common Stock | LTM Mar 2026 | 19.77M | — | +92.6% |
SPTXSeaport Therapeutics, Inc. Common Stock | — | — | — | — |
| Peer median (excluding SPTX) | 43.04M | +10.0% | +3.3% | |
Competitors are the stored peer set for SPTX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Seaport Therapeutics, Inc. Common Stock
NASDAQ:SPTX
Intrinsic Alpha fair value
Locked
Current Price
$18.31
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.